Add to your lists

Recommended Content

Picture of All-In Podcast
All-In Podcast

LA's Wildfire Disaster, Zuck Flips on Free Speech, Why Trump Wants Greenland

Jan. 11, 2025, 2:08 a.m.

No Paywall
Picture of Tech Investment Ideas
Tech Investment Ideas
Website logo

ASML's Strategy to Extend Moore's Law

Jan. 7, 2025, 9:50 a.m.

No Paywall
Picture of Platformer
Platformer
Website logo

OpenAI says it knows how to make superintelligence now

Jan. 7, 2025, 1:32 a.m.

Some Paywall
Picture of Tanay’s Newsletter
Tanay’s Newsletter
Website logo

Comparing the Financials of Databricks and Snowflake

Dec. 30, 2024, 11:35 p.m.

No Paywall
Picture of The Entertainment Strategy Guy
The Entertainment Strategy Guy
Website logo

The Future of TV or Just Another Netflix Hit?

Dec. 19, 2024, 12:10 a.m.

No Paywall
FinBrowser logo
Login Sign Up

How would you rate this source in terms of content quality?
Source Picture

Fierce Biotech

Picture of Fierce Biotech

Tags

Online Publication

Similiar Sources

Picture of BioPharma Dive
BioPharma Dive
Biotech - News 8.0
Picture of Biopharma Reporter
Biopharma Reporter
Biotech - News 8.0
Picture of Cafepharma
Cafepharma
Biotech - News 8.0
Picture of Drug Delivery Business
Drug Delivery Business
Biotech - News 8.0
Picture of Drugs.com
Drugs.com
Biotech - News 8.0
Picture of Evaluate
Evaluate
Biotech - News 8.0
Picture of GEN
GEN
Biotech - News 8.0
Picture of Labiotech
Labiotech
Biotech - News 8.0
Picture of Pharmafile
Pharmafile
Biotech - News 8.0
Picture of PharmaLive
PharmaLive
Biotech - News 8.0

Summary

Sector Biotech
Content Type News
Website Other
Paywall No

Ratings

Average Rating 8.0
Ratings 1
Your Rating Rate
Ranking 707

Content

Picture of Fierce Biotech
Fierce Biotech
Website logo

Labcorp launches bird flu test amid first severe case in the US

Dec. 18, 2024, 8:01 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Alphabet spinoff SandboxAQ raises $300M fund for 'next wave of AI'

Dec. 18, 2024, 6:40 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Merck KGaA’s MilliporeSigma absorbs Dutch organoid maker HUB Organoids

Dec. 18, 2024, 4:50 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Ring Therapeutics lays off just under half of staff in 2nd wave of cuts this year, CEO set to step down

Dec. 18, 2024, 4:32 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

BD, Babson Diagnostics expand fingertip blood draws to urgent care clinics, doctors’ offices

Dec. 17, 2024, 6:46 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Dexcom taps generative AI lifestyle tips for its Stelo glucose sensor

Dec. 17, 2024, 4:22 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

mRNA vaccine from CDC and Moderna protects ferrets from current avian influenza strain

Dec. 17, 2024, 3:46 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Sanofi, Teva look to 'next frontier' in IBD treatment after TL1A antibody hits mark in midstage trial

Dec. 17, 2024, 2:32 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Biomea's diabetes drug improves glucose control 3 months after FDA hold lifted

Dec. 17, 2024, 2:22 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Cash-strapped Portage finds hope in sale of lead asset, subsidiary to Immunova

Dec. 17, 2024, 12:50 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Fresh off $120M raise, AI-powered Terray is teaming up with Gilead in multi-pronged R&D pact

Dec. 17, 2024, 12:38 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Merck drops TIGIT asset and LAG-3 program, discontinuing several phase 3 trials

Dec. 16, 2024, 10:39 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

American Society of Hematology member surveys identify barriers to improving diversity in clinical trials

Dec. 16, 2024, 9:23 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

UCB's orchestra hits dud note: Novartis-partnered Parkinson's asset fails phase 2

Dec. 16, 2024, 7:57 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Roche mothballs another hemophilia A gene therapy under Spark amid plans to debut new hematologic asset

Dec. 16, 2024, 4:27 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Candid Therapeutics unwraps three new collaborations to discover and develop T-cell engager antibodies

Dec. 16, 2024, 4:01 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Incyte scraps anemia program after drug fails to improve symptoms in rare blood cancer

Dec. 13, 2024, 7:01 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Medtronic's latest ingestible PillCam completes first patient GI procedure

Dec. 13, 2024, 5:04 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

iTeos deprioritizes cancer candidate despite 'encouraging' phase 2 data

Dec. 12, 2024, 7:32 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

FDA expands use of J&J's Impella heart pumps to pediatric patients

Dec. 12, 2024, 7:31 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Evotec, Novo Nordisk's drug discovery accelerator debuts first 3 projects, adds 5 partners

Dec. 12, 2024, 7:07 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

PeptiDream’s macrocyclic peptides preserve muscle mass in mice given semaglutide

Dec. 12, 2024, 5:18 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Tenpoint, Visus merge in effort to push presbyopia-correcting eye drop over FDA finish line

Dec. 12, 2024, 3:46 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Elevation lifts HER3 ADC toward clinic with $368M Synaffix deal

Dec. 12, 2024, 2:21 p.m.

No Paywall
Picture of Fierce Biotech
Fierce Biotech
Website logo

Keros' stock tanks after halting 2 arms of hypertension trial over fluid buildups around heart

Dec. 12, 2024, 11:31 a.m.

No Paywall